• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: QUEST INTL., INC. BLOOD TEST: HSV-2 IGG, TYPE SPECIFIC AB; ENZYME LINKED IMMUNOSORBENT ASSAY, HERPES SIMPLEX VIRUS, HSV-2

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

QUEST INTL., INC. BLOOD TEST: HSV-2 IGG, TYPE SPECIFIC AB; ENZYME LINKED IMMUNOSORBENT ASSAY, HERPES SIMPLEX VIRUS, HSV-2 Back to Search Results
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/27/2023
Event Type  malfunction  
Event Description
(b)(6) did a 10-test std panel on (b)(6) 2023 that included the hsv-2 igg, type specific ab test that yielded a positive result (2.59h).I ordered their hsv-2 igg inhibition, ia test on (b)(6) 2023 and the igg screening assay yielded a negative result (< 0.90).I'm asymptomatic of hsv-2.As part of the hsv-2 igg inhibition, ia they redo the hsv-2 igg screening assay and that returned a < 0.90 (thus inhibition could not be determined) only 3 days after the hsv-2 igg, type specific ab.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLOOD TEST: HSV-2 IGG, TYPE SPECIFIC AB
Type of Device
ENZYME LINKED IMMUNOSORBENT ASSAY, HERPES SIMPLEX VIRUS, HSV-2
Manufacturer (Section D)
QUEST INTL., INC.
MDR Report Key18486317
MDR Text Key332802378
Report NumberMW5150077
Device Sequence Number1
Product Code LGC
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 01/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/09/2024
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age35 YR
Patient SexMale
Patient Weight113 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-